Skip to main content

Open Access 24.10.2019 | Original Article

Evaluation of preoperative risk factors for postpancreatectomy hemorrhage

verfasst von: Wataru Izumo, Ryota Higuchi, Takehisa Yazawa, Shuichiro Uemura, Masahiro Shiihara, Masakazu Yamamoto

Erschienen in: Langenbeck's Archives of Surgery

Abstract

Purpose

To investigate the risk factors for post-pancreatectomy hemorrhage (PPH).

Methods

The incidence, outcome, and risk factors for PPH were evaluated in 1169 patients who underwent pancreatectomy.

Results

The incidence and mortality rates of PPH were 3% and 11% in all pancreatectomies, 4% and 11% in pancreatoduodenectomy, 1% and 20% in distal pancreatectomy, and 3% and 0% in total pancreatectomy, respectively. Male sex [odds ratio (OR) 2.32], body mass index (BMI) ≥ 25 kg/m2 (OR 3.70), absence of diabetes mellitus (DM; HbA1c ≤ 6.2%; OR 3.62), and pancreatoduodenectomy (OR 3.06) were risk factors for PPH after all pancreatectomies. The PPH incidence was 0%, 1%, 2%, 6%, and 20% in patients with risk scores of 0 (n = 65), 1 (n = 325), 2 (n = 455), 3 (n = 299), and 4 (n = 25), respectively. The differences between risk-score groups 0–2 (2%) and 3–4 (7%) were significant (P < 0.05, OR 4.7). In patients who had undergone pancreatoduodenectomy, postoperative pancreatic fistula (POPF; OR 31.7) and absence of DM (OR 3.45) were risk factors for PPH. There was no significant association between POPF and PPH after distal pancreatectomy (P = 0.28). The incidence of POPF post-pancreatoduodenectomy was 20%. BMI ≥ 25 kg/m2 (OR 3.17), serum albumin < 3.5 g/dl (OR 1.77), absence of DM (OR 1.75), distal extrahepatic bile duct carcinoma (OR 4.05), and carcinoma of the papilla of Vater (OR 5.19) were risk factors for POPF post-pancreatoduodenectomy.

Conclusion

Our study clarified the preoperative risk factors for PPH and recommends using a risk scoring system that includes “absence of DM” for predicting PPH.
Begleitmaterial
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00423-019-01830-w) contains supplementary material, which is available to authorized users.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Recently, the surgical technique for pancreatectomy has improved; however, pancreatectomy is associated with many complications postsurgery [14]. Although the frequency of postpancreatectomy hemorrhage (PPH) is not high, it results in severe adverse outcomes. The incidence rate of PPH and the mortality rate following PPH have been reported to be 3–16% and 16–36%, respectively [412]. The International Study Group on Pancreatic Surgery (ISGPS) defined PPH in 2007 [13]. Some studies have reported that postoperative pancreatic fistula (POPF), postoperative bile leakage, and postoperative abdominal infection are risk factors for PPH [512]. Although this information is useful, it includes intraoperative and postoperative factors that can only be known after surgery. Other studies reported that male sex, high body mass index (BMI), and low serum albumin (Alb) levels, which are preoperative factors, are associated with PPH [8, 10, 12, 14]. However, the preoperative risk factors for PPH have not been fully elucidated yet. Therefore, the aim of this study was to clarify the preoperative risk factors for PPH.

Material and methods

Between 2005 and 2018, 1169 patients underwent pancreatectomy at the Department of Surgery, Institute of Gastroenterology, Tokyo Woman’s Medical University. Parameters that were evaluated included the incidence, outcomes, time of onset, location, severity, grade, and risk factors of PPH. Clinical data that were collected and examined included age; sex; preoperative BMI; white blood cell (WBC) count; serum levels of Alb, C-reactive protein (CRP), and hemoglobin A1c (HbA1c); preoperative drainage for obstructive jaundice; preoperative treatment (chemotherapy or chemoradiotherapy); operative procedure, duration of surgery; amount of intraoperative blood loss; vascular resection; pancreatojejunostomy (PJ) anastomosis method; falciform ligament wrapping of the gastroduodenal artery (GDA) stump; clipping of the GDA stump; PJ stent; pathological tissue type; pancreatic fistula; delayed gastric emptying (DGE); and postoperative bile leakage. The significant factors identified by multivariate analysis to cause PPH were defined as risk factors for PPH. The risk score was calculated, with 1 point assigned to each risk factor, and the incidence of PPH was examined for each risk score number.
The patients’ characteristics for all pancreatectomies are shown in Supplemental Table 1. Six hundred fifty-five patients (56%) were men; the median preoperative BMI level was 21.5 kg/m2 (range 14.3–36.8 kg/m2); 421 patients (36%) had diabetes mellitus (DM); 675 patients (57%) underwent pancreatoduodenectomy (PD); 211 patients (18%) had POPF grade B (15.6%, 182 patients) or C (2.5%, 29 patients); 279 (24%) patients underwent HDL wrapping of the GDA stump; none of the patients with omental grafts underwent GDA stump wrapping, and all patients underwent vascularized graft placement of the GDA stump using the falciform ligament; 26 (2%) patients underwent clipping of the GDA stump.

Definitions

PPH, POPF, and DGE

The PPH, POPF, and DGE grades were defined using ISGPS guidelines [13, 15, 16] and categorized into 3 (grades A, B, and C). Since the grade A cases were not clinically relevant and not a target for treatment, we only considered grade B or C cases in this study. Patients with grades B or C PPH were at risk for death, and blood transfusion, angiography, embolization, relaparotomy, and intensive treatment in the intensive care unit were needed to improve the condition of these patients.

Diabetes mellitus

HbA1c level ≥ 6.3% was defined as DM in this study because the normal value of HbA1c in Japan is determined to be ≤ 6.2%.

Surgical policy

Pancreatectomy with typical lymph node dissection for carcinoma involves regional lymph node dissection, and partial lymph node dissection was performed for inflammation and low malignant tumors. Regional lymph node dissection involves excision of the plexus in the right half of the SMA and dissection of the hepatoduodenal ligament from the left and right hepatic artery bifurcation to the upper margin of the pancreas. The reconstruction method was the Child’s procedure. All patients underwent PJ anastomosis for gastroenterological reconstruction, and no patient underwent pancreatogastrostomy. Usually, the GDA stump was double ligated, and beginning in 2018, additional clipping (Hem-o-lok clip®; Telefrex Medical, USA) was performed on the GDA stump. Moreover, beginning in 2010, the GDA stump was wrapped with the falciform ligament. We performed duct-to-mucosa anastomosis for PJ until 2016 and modified Blumgart anastomosis after 2017. The surgeon chose PJ stenting if the diameter of the PJ anastomosis was narrow, reconstruction was difficult, and the remaining pancreas was soft.

Mortality rate

The rate of inpatient death related to PPH during hospitalization was used as the mortality rate in this study.

Statistical analysis

Univariate and multivariate logistic regression analyses were performed to determine independent predictors of PPH in patients who had undergone pancreatectomy. Only factors that were significant on univariate analysis were subjected to multivariate analysis. A P value < 0.05 was considered statistically significant. All the analyses were performed using JMP version 12.1.9 for Windows (SAS Institute Inc., Cary, NC, USA).

Results

Incidence, mortality, classification, reason, and treatment of PPH after all pancreatectomies (Table 1

The incidence of PPH grades B or C was 3% in all 1169 patients undergoing pancreatectomy, 4% in the 675 patients undergoing PD, 1% in the 406 patients undergoing distal pancreatectomy (DP), and 3% in the 88 patients undergoing total pancreatectomy (TP). The incidence of late onset time, extraluminal location, high severity, bleeding from pseudoaneurysm, and interventional radiology treatment were 96%, 74%, 81%, 66%, and 63%, respectively. The median onset time of all PPH and bleeding from pseudoaneurysms from the initial surgery was 22 and 21 days, respectively. Mortality among patients with PPH was 11%. These patients died from multiple organ dysfunction caused by bleeding from pseudoaneurysms. The overall mortality rate within 30 and 90 days was 0.3% (3/1169) and 0.6% (7/1169), respectively. Mortality from PPH within 30 and 90 days was 0.2% (2/1169) and 0.3% (3/1169), respectively.
Table 1
Incidence, mortality, classification, reason, and treatment of post-pancreatectomy hemorrhage grades B or C after all pancreatectomy
Category
Definition
All
PD
DP
TP
Total number of PPHs
 
n = 35
n = 27
n = 5
n = 3
Incidence of PPH
 
3% (35/1169)
4% (27/675)
1% (5/406)
3% (3/88)
Mortality among patients with PPH
4 (11%)
3 (11%)
1 (20%)
0 (0%)
Median onset time from initial surgery (days), (range)
22 (0–65)
24 (0–47)
9 (0–27)
2 (0–65)
Time of onset
Early/late
4 (4%)/31 (96%)
1 (4%)/26 (96%)
1 (20%)/4 (80%)
2 (67%)/1 (33%)
Location
Intraluminal/extraluminal
9 (26%)/26 (74%)
7 (26%)/20 (74%)
1 (20%)/4 (80%)
1 (33%)/2 (67%)
Severity
Mild/severe
9 (19%)/26 (81%)
5 (19%)/22 (81%)
2 (40%)/3 (60%)
2 (67%)/1 (33%)
Reason
Pseudoaneurysm
GDA/HA/SMA/SPA
Bleeding from the stump of the pancreas, greater omentum or retroperitoneal
22 (66%)
13/5/1/3
7 (19%)
18 (66%)
12/5/1/0
5 (19%)
3 (60%)
1/0/0/2
1 (20%)
1 (33%)
0/0/0/1
1 (33%)
Gastrointestinal bleeding
6 (15%)
4 (15%)
1 (20%)
1 (33%)
Treatment
Interventional radiology
Conservative treatment with blood transfusion
Endoscopic treatment
Surgery
Interventional radiology plus surgery
19 (63%)
6 (15%)
5 (11%)
4 (7%)
1 (4%)
17 (63%)
4 (15%)
3 (11%)
2 (7%)
1 (4%)
2 (40%)
1 (20%)
1 (20%)
1 (20%)
0 (0%)
0 (0%)
1 (33%)
1 (33%)
1 (0%)
0 (0%)
PPH postpancreatectomy hemorrhage, GDA gastroduodenal artery, HA hepatic artery, SMA superior mesenteric artery, SPA splenic artery, PD pancreatoduodenectomy, DP distal pancreatectomy, TP total pancreatectomy
Classification categories were defined by the International Study Group of Pancreatic Surgery [7]
Time of onset: early hemorrhage means that bleeding occurred ≤ 24 h after the end of the operation; late hemorrhage means that bleeding occurred > 24 h after the end of the index operation
Location: intraluminal hemorrhage means bleeding from the gastrointestinal tract; extraluminal hemorrhage means bleeding from the abdominal cavity
Severity: Mild means that the patient’s condition was not severe enough to necessitate invasive treatment; severe means that the patient’s condition was poor, and it was necessary to perform intensive treatment

Univariate and multivariate analyses of risk factors for PPH after all pancreatectomies (Table 2) and PPH rate by independent risk factors (Supplemental Table 2)

In multivariate analysis, male sex (odds ratio [OR] 2.32), BMI ≥ 25 kg/m2 (OR 3.70), absence of DM (OR 3.62), and PD (OR 3.06) were significant independent risk factors for PPH in all patients undergoing pancreatectomy (P < 0.05). When assessing using these risk factors, the incidence of PPH after all pancreatectomies in patients with a risk score of 0 (n = 65), 1 (n = 325), 2 (n = 455), 3 (n = 299), and 4 (n = 25) was 0%, 1%, 2%, 6%, and 20% (P < 0.0001), respectively (Supplemental Table 2). The differences between risk-score groups 0–2 (2%) and 3–4 (7%) were significant (P < 0.05, OR 4.7).
Table 2
Univariate and multivariate analyses of risk factors for post-pancreatectomy hemorrhage grades B or C after all pancreatectomy
   
Univariate
Multivariate
Risk factors
Definition
n
PPH
OR
(95% CI)
P value
OR
(95% CI)
P value
Age (years)
< 65
≥ 65
493
676
12 (2.4%)
23 (3.4%)
1
1.41 (0.70–2.87)
0.34
  
Sex
Female
Male
518
651
8 (1.5%)
27 (4.2%)
1
2.76 (1.24–6.12)
0.0013
1
2.32 (1.02–5.26)
0.034
BMI (kg/m2)
< 25
≥ 25
1011
158
24 (2.4%)
11 (7.0%)
1
3.08 (1.48–6.41)
0.0027
1
3.70 (1.71–8.04)
0.0009
WBC (/ul)
< 8000
≥ 8000
1093
76
3 (4.0%)
32 (2.9%)
1
1.36 (0.41–4.56)
0.62
  
Alb (g/dl)
≥ 3.5
< 3.5
1040
129
26 (2.5%)
9 (7.0%)
1
2.92 (1.34–6.39)
0.0071
1
2.17 (0.95–4.98)
0.066
CRP (mg/dl)
< 1
≥ 1
1055
114
29 (2.8%)
6 (5.3%)
1
1.97 (0.80–4.84)
0.14
  
DM
Presence
Absence
421
748
6 (1.4%)
29 (3.9%)
1
2.79 (1.15–6.78)
0.023
1
3.62 (1.46–8.99)
0.0056
Pretreatment *
With
Without
37
1132
1 (2.7%)
34 (3.0%)
1
1.11 (0.15–8.37)
0.92
  
Operative procedure
DP
406
5 (1.2%)
1
 
1
 
PD
TP
675
88
27 (4.0%)
3 (3.4%)
3.34 (1.28–8.75)
2.83 (0.66–12.1)
0.014
0.16
3.06 (1.12–8.36)
3.27 (0.73–14.7)
0.029
0.12
Operation time (min)
< 360
≥ 360
597
572
15 (2.5%)
20 (3.5%)
1
1.41 (0.71–2.77)
0.33
  
Blood loss (ml)
< 1200
≥ 1200
1010
159
26 (2.6%)
9 (5.7%)
1
2.27 (1.04–4.94)
0.039
1
1.50 (0.66–3.43)
0.34
Vascular resection
Without
967
29 (3.0%)
1
0.98
  
With
202
6 (3.0%)
0.99 (0.41–2.42)
   
*Pretreatment was preoperative chemotherapy or chemoradiotherapy
**Delayed gastric emptying was defined by the International Study Group on Pancreatic Surgery
PPH postpancreatectomy hemorrhage, OR odds ratio, CI confidence interval, BMI body mass index, WBC white blood cells, Alb albumin, CRP C-reactive protein, DM diabetes mellitus, DP distal pancreatectomy, PD pancreatoduodenectomy, TP total pancreatectomy, DGE delayed gastric emptying

Univariate and multivariate analyses of risk factors for PPH after PD (Table 3)

Because PD was risk factor of PPH after all pancreatectomies, we evaluated risk factors for PPH after PD, excluding DP and TP. In multivariate analysis, POPF (OR 31.7) and absence of DM (OR 3.45) were independent risk factors for PPH after PD (P < 0.05). There was no significant difference in the incidence of PPH between patients with and without falciform ligament wrapping of the GDA stump [5.7% (11/276) and 2.8% (16/399), respectively; P = 0.059]. The incidence of POPF after PD was 20%.
Table 3
Univariate and multivariate analyses of risk factors for postpancreatectomy hemorrhage grades B or C after pancreatoduodenectomy
   
Univariate
Multivariate
Risk factors
Definition
n
PPH
OR
(95% CI)
P value
OR
(95% CI)
P value
Period
2005–2011
2012–2018
324
351
9 (2.8%)
18 (5.1%)
1
1.89 (0.84–4.27)
0.12
  
Age (years)
< 65
≥ 65
251
424
8 (3.2%)
19 (4.5%)
1
1.43 (0.61–3.30)
0.41
  
Sex
Female
Male
264
411
7 (2.7%)
20 (4.9%)
1
1.88 (0.78–4.51)
0.15
  
BMI (kg/m2)
< 25
≥ 25
595
80
20 (3.4%)
7 (8.8%)
1
2.76 (1.13–6.74)
0.021
1
2.22 (0.77–6.43)
0.14
WBC (/ul)
< 8000
≥ 8000
628
47
25 (4.0%)
2 (4.3%)
1
1.07 (0.25–4.67)
0.93
  
Alb (g/dl)
≥ 3.5
< 3.5
563
112
17 (3.0%)
10 (8.9%)
1
2.68 (1.17–6.12)
0.016
1
2.04 (0.79–5.28)
0.14
CRP (mg/dl)
< 1
≥ 1
577
98
22 (3.8%)
5 (5.1%)
1
1.36 (0.50–3.67)
0.56
  
DM
Presence
Absence
241
434
4 (1.7%)
23 (5.3%)
1
3.32 (1.13–9.70)
0.021
1
3.45 (1.06–11.3)
0.040
Pre-drainage
Without
With
404
271
13 (3.2%)
14 (5.2%)
1
1.64 (0.76–3.54)
0.21
  
Pretreatment *
With
Without
29
646
1 (3.5%)
26 (4.0%)
1
1.17 ‘0.15–8.97)
0.87
  
Operation time (min)
< 360
≥ 360
220
455
9 (4.1%)
18 (4.0%)
1.04 (0.46–2.34)
1
0.93
  
Blood loss (ml)
< 1200
≥ 1200
566
109
18 (3.2%)
9 (8.4%)
1
2.81 (1.23–6.43)
0.011
1
1.74 (0.65–4.66)
0.27
Vascular resection
Without
With
566
109
22 (3.9%)
5 (4.6%)
1
1.19 (0.44–3.21)
0.73
  
PJ anastomosis method
Duct-to mucosa
Modified Blumgart
580
95
23 (4.0%)
4 (4.2%)
1
1.06 (0.36–3.15)
0.91
  
Falciform ligament wrapping of GDA stump
Without
With
399
276
16 (2.8%)
11 (5.7%)
1
2.13 (0.97–4.66)
0.059
  
Clipping of GDA stump
Without
With
657
18
26 (4.0%)
1 (5.6%)
1
1.43 (0.18–11.1)
0.75
  
PJ stent
Without
With
318
357
8 (2.5%)
19 (5.3%)
1
   
2.18 (0.94–5.05)
0.059
Pathological tissue type
PDAC
IPMN
DEBDC
PVC
Others
261
139
149
75
50
6 (2.3%)
3 (2.2%)
12 (8.1%)
4 (5.3%)
2 (4.0%)
1
 
1
 
0.94 (0.23–3.82)
3.74 (1.37–10.2)
2.40 (0.66–8.75)
1.78 (0.35–9.07)
0.93
0.010
0.18
0.49
1.13 (0.22–5.72)
1.49 (0.47–4.75)
0.81 (0.19–3.49)
2.14 (0.34–13.3)
0.88
0.50
0.78
0.42
POPF**
None or A
B or C
542
133
3 (0.6%)
24 (18.1%)
1
39.6 (11.8–133.7)
< 0.0001
1
31.7 (8.94–112.2)
< 0.0001
DGE***
None or A
B or C
626
49
25 (4.0%)
2 (4.1%)
1
1.02 (0.23–4.45)
0.98
  
Bile leakage
Without
With
665
10
26 (3.9%)
1 (10.0%)
1
2.73 (0.33–22.4)
0.33
  
*Pretreatment was preoperative chemotherapy or chemoradiotherapy
**Postoperative pancreatic fistula was defined by the International Study Group on Pancreatic Surgery
***Postoperative delayed gastric emptying was defined by the International Study Group on Pancreatic Surgery
PPH postpancreatectomy hemorrhage, OR odds ratio, CI confidence interval, BMI body mass index, WBC white blood cell, Alb albumin, CRP C-reactive protein, DM diabetes mellitus, GDA gastroduodenal artery, PJ stent pancreatojejunostomy stent, PDAC pancreatic ductal adenocarcinoma, DEBDC distal extrahepatic bile duct carcinoma, IPMN intraductal papillary mucinous neoplasm, PVC carcinoma of the papilla of Vater, POPF postoperative pancreatic fistula, DGE delayed gastric emptying

Univariate and multivariate analyses of risk factors for POPF after PD (Table 4)

Because POPF was risk factor for PPH after PD, we assessed risk factors for POPF after PD. In multivariate analysis, BMI ≥ 25 kg/m2 (OR 3.17), Alb < 3.5 g/dl (OR 1.77), absence of DM (OR 1.75), distal extrahepatic bile duct carcinoma (OR 4.05), and carcinoma of the papilla of Vater (PVC) (OR 5.19) were independent risk factors for POPF after PD.
Table 4
Univariate and multivariate analyses of preoperative risk factors for postoperative pancreatic fistula grades B or C after pancreatoduodenectomy
   
Univariate
Multivariate
Risk factors
Definition
n
POPF
OR
(95% CI)
P value
OR
(95% CI)
P value
Age (years)
< 65
≥ 65
251
424
42 (16.8%)
91 (21.5%)
1
1.36 (0.91–2.04)
0.14
  
Gender
Female
Male
264
411
37 (14.0%)
96 (23.4%)
1
1.87 (1.23–2.83)
0.0024
1
1.57 (0.99–2.46)
0.05002
BMI (kg/m2)
< 25
≥ 25
595
80
106 (17.8%)
27 (33.8%)
1
2.35 (1.41–3.91)
0.0015
1
3.17 (1.81–5.56)
< 0.0001
WBC (/ul)
< 8000
≥ 8000
628
47
120 (19.1%)
13 (27.7%)
1
1.62 (0.83–3.16)
0.16
  
Alb (g/dl)
≥ 3.5
< 3.5
563
112
99 (17.6%)
34 (30.4%)
1
1.93 (1.22–3.06)
0.0050
1
1.77 (1.07–2.93)
0.027
CRP (mg/dl)
< 1
≥ 1
577
98
108 (18.7%)
25 (25.5%)
1
1.49 (0.90–2.45)
0.12
  
DM
Presence
Absence
241
434
35 (14.5%)
98 (22.6%)
1
1.72 (1.12–2.62)
0.0123
1
1.75 (1.10–2.78)
0.019
Pre-drainage
Without
With
404
271
65 (16.1%)
68 (25.1%)
1
1.75 (1.19–2.56)
0.0042
1
0.69 (0.40–1.17)
0.17
Pretreatment *
With
Without
646
29
126 (19.5%)
7 (24.1%)
1
1.31 (0.55–3.14)
0.54
  
Pathological tissue type
PDAC
IPMN
DEBDC
PVC
Others
262
139
149
75
50
30 (11.5%)
18 (13.0%)
49 (32.9%)
29 (38.7%)
7 (14.0%)
1
 
1
 
1.15 (0.62–2.15)
3.79 (2.27–6.32)
4.88 (2.67–8.89)
1.26 (0.52–3.05)
0.66
< 0.0001
< 0.0001
0.61
1.14 (0.60–2.20)
4.05 (2.15–7.62)
5.19 (2.70–9.97)
1.05 (0.42–2.65)
0.69
< 0.0001
< 0.0001
0.92
*Pretreatment was preoperative chemotherapy or chemoradiotherapy
POPF postoperative pancreatic fistula, OR odds ratio, CI confidence interval, BMI body mass index, WBC white blood cell, Alb albumin, CRP c-reactive protein, DM diabetes mellitus, PJ stent pancreatojejunostomy stent, PDAC pancreatic ductal adenocarcinoma, DEBDC distal extrahepatic bile duct carcinoma, IPMN intraductal papillary mucinous neoplasm, PVC carcinoma of the papilla of Vater

Association between POPF and PPH after DP and PD

The incidence of POPF after DP was 19% (78/406). There was no significant difference in the incidence of POPF between DP and PD [20% (133/675), P = 0.84]. Unlike with PD where the OR of 31.7, there was also no significant association between POPF and PPH after DP [3% (2/78) in patients with POPF and 1% (3/328) in patients without POPF; P = 0.28].

Discussion

This study indicates that absence of DM (HbA1c level ≤ 6.2%) is an independent risk factor for PPH after all pancreatectomies and PD and for POPF after PD; a risk scoring system including the absence of DM may be useful for predicting PPH before surgery. By determining the value of HbA1c level (≤ 6.2%), we can predict PPH more easily. This is a new finding that has not been reported before.
In recent years, PPH has a low frequency, but it has a poor outcome. POPF, DGE, wound infection, and abdominal abscess are major complications of PD [3, 4, 17]. Previous literatures reported that the incidence of PPH was only 3–16%; however, mortality among patients with PPH was 16–36% [412]. In this study, the incidence and mortality rates of patients with PPH were 3% (35/1169) and 11% (4/35), respectively (Table 1), after all pancreatectomies. PPH was the major cause of death within 30 days after pancreatectomy. Previous literatures also reported that short-term outcomes after pancreatectomy were better in high-volume centers than in low-volume centers (mortality rate 0.9–6.0% vs. 13.0–18.8%) [9, 1820].
Some previous reports about intraoperative and postoperative factors showed that vascular resection, pancreaticogastrostomy, postoperative bile leakage, postoperative abdominal infection, and especially POPF were independent risk factors for PPH [512]. PPH from a pseudoaneurysm of the GDA stump usually results from POPF [9, 21], and the median onset time of PPH was reported as 5–13 days (range 0–58 days) [6, 10, 12]. In our study, similar results were noted, and it is necessary to pay attention to the onset time from initial surgery (median onset time 22 days, range 0–65 days; Table 1). Previous literatures have mentioned preoperative risk factors for PPH such as male sex, high BMI, and low Alb level [8, 10, 12, 14]; our study also showed a similar result. Additionally, in our study, “absence of DM (HbA1c level ≤ 6.2%)” was one of the significant independent risk factors for PPH after all pancreatectomies and PD, which has not been reported.
Insulin acts to promote secretion of pancreatic exocrine cells [22]. It has been reported that the pancreatic exocrine function declined as insulin secretion decreased and the exocrine pancreatic glands atrophied [23]. This means that in patients with DM, the pancreatic parenchyma atrophies and becomes hard, and in patients without DM, the pancreatic parenchyma is thick and soft. Traditionally, patients with a soft pancreas, thick parenchyma, and thin pancreatic duct are considered at risk for POPF after PD [2427]. Pancreatic exocrine function is an important determinant of POPF after PD [28]. In pancreatic carcinoma, it has been reported that pancreatic parenchyma atrophy is seen from the onset of illness and the main pancreatic duct is dilated [29]. In the same way, in a patient with intraductal papillary mucinous neoplasm, the main pancreatic duct is slightly dilated and the pancreatic parenchyma is relatively decreased and atrophic. In contrast, in patients with distal extrahepatic bile duct carcinoma, main pancreatic duct dilation and pancreatic parenchyma atrophy are rare. Patients with a thick and soft pancreatic parenchyma have a high possibility of POPF and a high risk of PPH after pancreatectomy. In situations where there is no clear definition of the thickness and hardness of the pancreas and it is difficult to judge them preoperatively, the presence or absence of DM (HbA1c level ≤ 6.2%) is considered to be one of the good indicators.
Previous literatures reported that omental flaps or grafts around various anastomoses after PD could reduce the incidence of POPF and PPH [30, 31]. In this study, the statistical analysis did not show a significant benefit of wrapping the GDA stump for preventing PPH. We believe we cannot draw sufficient statistical conclusions because of differences in surgical techniques and instruments, differences in applications and methods of round ligament wrapping, and the limited use of clips in recent cases. Hence, further clinical evaluation for this is necessary. In addition, pancreatic surgery in patients at high risk for developing PPH may require new precautions to further reduce the incidence of PPH.

Limitations

Patients from different periods over the 14-year span of the study underwent different diagnostic and treatment modalities owing to the advances in techniques that occurred over time; these variations may have skewed the outcomes of patients treated during the different periods of the study. Moreover, our investigation had a retrospective design and was performed at a single institution; the biases inherent in such settings cannot be completely excluded.

Conclusion

Male sex, BMI ≥ 25 kg/m2, absence of DM (HbA1c level ≤ 6.2%), and PD are independent risk factors for PPH after all pancreatectomies. A risk scoring system including the new preoperative risk factor “absence of DM” would be useful for predicting PPH.

Acknowledgments

Wataru Izumo received the Grant for Young Doctors of Abdominal Emergency Clinical Research from the Japanese Society for Abdominal Emergency Medicine (2017-Y-02).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the institutional review board of Tokyo Women’s Medical University (approval number 5083) and the Japanese Society for Abdominal Emergency Medicine (approval number 19–2). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration. This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Anhänge

Electronic supplementary material

Literatur
1.
Zurück zum Zitat Kimura W (2008) Strategies for the treatment of invasive ductal carcinoma of the pancreas and how to achieve zero mortality for pancreaticoduodenectomy. J Hepato-Biliary-Pancreat Surg 15(3):270–277CrossRef Kimura W (2008) Strategies for the treatment of invasive ductal carcinoma of the pancreas and how to achieve zero mortality for pancreaticoduodenectomy. J Hepato-Biliary-Pancreat Surg 15(3):270–277CrossRef
2.
Zurück zum Zitat Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y et al (2012) Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19(3):230–241CrossRef Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y et al (2012) Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19(3):230–241CrossRef
3.
Zurück zum Zitat Kimura W, Miyata H, Gotoh M, Hirai I, Kenjo A, Kitagawa Y et al (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259(4):773–780CrossRef Kimura W, Miyata H, Gotoh M, Hirai I, Kenjo A, Kitagawa Y et al (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259(4):773–780CrossRef
4.
Zurück zum Zitat Balcom JH, Rattner DW, Warshaw AL, Chang Y, Fernandez-del CC (2001)Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136(4):391–398CrossRef Balcom JH, Rattner DW, Warshaw AL, Chang Y, Fernandez-del CC (2001)Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 136(4):391–398CrossRef
5.
Zurück zum Zitat Yekebas EF, Wolfram L, Cataldegirmen G, Habermann CR, Bogoevski D, Koenig AM et al (2007) Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections. Ann Surg 246(2):269–280CrossRef Yekebas EF, Wolfram L, Cataldegirmen G, Habermann CR, Bogoevski D, Koenig AM et al (2007) Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections. Ann Surg 246(2):269–280CrossRef
6.
Zurück zum Zitat Darnis B, Lebeau R, Chopin-Laly X, Adham M (2013) Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database. Langenbeck's Arch Surg 398:441–448CrossRef Darnis B, Lebeau R, Chopin-Laly X, Adham M (2013) Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database. Langenbeck's Arch Surg 398:441–448CrossRef
7.
Zurück zum Zitat Roulin D, Cerantola Y, Demartines N, Schäfer M (2011) Systematic review of delayed postoperative hemorrhage after pancreatic resection. J Gastrointest Surg 15:1055–1062CrossRef Roulin D, Cerantola Y, Demartines N, Schäfer M (2011) Systematic review of delayed postoperative hemorrhage after pancreatic resection. J Gastrointest Surg 15:1055–1062CrossRef
8.
Zurück zum Zitat Wellner UF, Kulemann B, Lapshyn H, Hoeppner J, Sick O, Makowiec F et al (2014) Postpancreatectomy hemorrhage--incidence, treatment, and risk factors in over 1,000 pancreatic resections. J Gastrointest Surg 18(3):464–475CrossRef Wellner UF, Kulemann B, Lapshyn H, Hoeppner J, Sick O, Makowiec F et al (2014) Postpancreatectomy hemorrhage--incidence, treatment, and risk factors in over 1,000 pancreatic resections. J Gastrointest Surg 18(3):464–475CrossRef
9.
Zurück zum Zitat Grützmann R, Rückert F, Hippe-Davies N, Distler M, Saeger H-D(2012) Evaluation of the International Study Group of Pancreatic Surgery definition of post-pancreatectomy hemorrhage in a high-volume center. Surgery 151:612–620CrossRef Grützmann R, Rückert F, Hippe-Davies N, Distler M, Saeger H-D(2012) Evaluation of the International Study Group of Pancreatic Surgery definition of post-pancreatectomy hemorrhage in a high-volume center. Surgery 151:612–620CrossRef
10.
Zurück zum Zitat Feng J, Chen YL, Dong JH, Chen MY, Cai SW, Huang ZQ (2014)Post-pancreaticoduodenectomy hemorrhage: risk factors, managements and outcomes. Hepatobiliary Pancreat Dis Int 13(5):513–522CrossRef Feng J, Chen YL, Dong JH, Chen MY, Cai SW, Huang ZQ (2014)Post-pancreaticoduodenectomy hemorrhage: risk factors, managements and outcomes. Hepatobiliary Pancreat Dis Int 13(5):513–522CrossRef
11.
Zurück zum Zitat Gao Q-X, Lee H-Y, Wu W-H, Gao S, Yang Y-M, Ma IT et al (2012) Factors associated with post-pancreaticoduodenectomy hemorrhage: 303 consecutive cases analysis. Chin Med J 125:1571–1575PubMed Gao Q-X, Lee H-Y, Wu W-H, Gao S, Yang Y-M, Ma IT et al (2012) Factors associated with post-pancreaticoduodenectomy hemorrhage: 303 consecutive cases analysis. Chin Med J 125:1571–1575PubMed
12.
Zurück zum Zitat Gao F, Li J, Quan S, Li F, Ma D, Yao L et al (2016) Risk factors and treatment for hemorrhage after pancreaticoduodenectomy: a case series of 423 patients. Biomed Res Int 2016:2815693PubMedPubMedCentral Gao F, Li J, Quan S, Li F, Ma D, Yao L et al (2016) Risk factors and treatment for hemorrhage after pancreaticoduodenectomy: a case series of 423 patients. Biomed Res Int 2016:2815693PubMedPubMedCentral
13.
Zurück zum Zitat Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 142(1):20–25CrossRef Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 142(1):20–25CrossRef
14.
Zurück zum Zitat Wellner UF, Makowiec F, Sick O, Hopt UT, Keck T (2012) Arguments for an individualized closure of the pancreatic remnant after distal pancreatic resection. World J Gastrointest Surg 4(5):114–120CrossRef Wellner UF, Makowiec F, Sick O, Hopt UT, Keck T (2012) Arguments for an individualized closure of the pancreatic remnant after distal pancreatic resection. World J Gastrointest Surg 4(5):114–120CrossRef
15.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al (2005) International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13CrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al (2005) International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13CrossRef
16.
Zurück zum Zitat Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142(5):761–768CrossRef Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142(5):761–768CrossRef
17.
Zurück zum Zitat Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226(3):248–257 discussion 257-60CrossRef Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226(3):248–257 discussion 257-60CrossRef
18.
Zurück zum Zitat Gordon TA, Burleyson GP, Tielsch JM, Cameron JL (1995) The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 221(1):43–49CrossRef Gordon TA, Burleyson GP, Tielsch JM, Cameron JL (1995) The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 221(1):43–49CrossRef
19.
Zurück zum Zitat Sosa JA, Bowman HM, Gordon TA, Bass EB, Yeo CJ, Lillemoe KD et al (1998) Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228:429–438CrossRef Sosa JA, Bowman HM, Gordon TA, Bass EB, Yeo CJ, Lillemoe KD et al (1998) Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228:429–438CrossRef
20.
Zurück zum Zitat Lieberman MD, Kilburn H, Lindsey M, Brennan MF (1995) Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222:638–645CrossRef Lieberman MD, Kilburn H, Lindsey M, Brennan MF (1995) Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222:638–645CrossRef
21.
Zurück zum Zitat Fuks D, Piessen G, Huet E, Tavernier M, Zerbib P, Michot F et al (2009)Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg 197:702–709CrossRef Fuks D, Piessen G, Huet E, Tavernier M, Zerbib P, Michot F et al (2009)Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg 197:702–709CrossRef
22.
Zurück zum Zitat Williams JA, Goldfine ID (1985) The insulin-pancreatic acinar axis. Diabetes 34(10):980–986CrossRef Williams JA, Goldfine ID (1985) The insulin-pancreatic acinar axis. Diabetes 34(10):980–986CrossRef
23.
Zurück zum Zitat Adler G, Kern HF (1975) Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metab Res 7(4):290–296CrossRef Adler G, Kern HF (1975) Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metab Res 7(4):290–296CrossRef
24.
Zurück zum Zitat Sugimoto M, Takahashi S, Kojima M, Kobayashi T, Gotohda N, Konishi M (2017) In patients with a soft pancreas, a thick parenchyma, a small duct, and fatty infiltration are significant risks for pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg 21(5):846–854CrossRef Sugimoto M, Takahashi S, Kojima M, Kobayashi T, Gotohda N, Konishi M (2017) In patients with a soft pancreas, a thick parenchyma, a small duct, and fatty infiltration are significant risks for pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg 21(5):846–854CrossRef
25.
Zurück zum Zitat Kawai M, Kondo S, Yamaue H, Wada K, Sano K, Motoi F et al (2011) Predictive risk factors for clinically-relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of HepatoBiliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 18:601–608CrossRef Kawai M, Kondo S, Yamaue H, Wada K, Sano K, Motoi F et al (2011) Predictive risk factors for clinically-relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of HepatoBiliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 18:601–608CrossRef
26.
Zurück zum Zitat Ansorge C, Strömmer L, Andrén-Sandberg Å, Lundell L, Herrington MK, Segersvärd R (2012) Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg 99:1076–1082CrossRef Ansorge C, Strömmer L, Andrén-Sandberg Å, Lundell L, Herrington MK, Segersvärd R (2012) Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg 99:1076–1082CrossRef
27.
Zurück zum Zitat El Nakeeb A, Salah T, Sultan A, El Hemaly M, Askr W, Ezzat H et al (2013) Pancreatic anastomotic leakage after pancreaticoduodenectomy. Risk factors, clinical predictors, and management (single center experience). World J Surg 37:1405–1418CrossRef El Nakeeb A, Salah T, Sultan A, El Hemaly M, Askr W, Ezzat H et al (2013) Pancreatic anastomotic leakage after pancreaticoduodenectomy. Risk factors, clinical predictors, and management (single center experience). World J Surg 37:1405–1418CrossRef
28.
Zurück zum Zitat Hamanaka Y, Nishihara K, Hamasaki T, Kawabata A, Yamamoto S, Tsurumi M et al (1996) Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery 119(3):281–287CrossRef Hamanaka Y, Nishihara K, Hamasaki T, Kawabata A, Yamamoto S, Tsurumi M et al (1996) Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery 119(3):281–287CrossRef
29.
Zurück zum Zitat Masamune A, Shimosegawa T. Pancreatic stellate cells: a dynamic player of the intercellular communication in pancreatic cancer. Clin Res Hepatol Gastroenterol 2015; 39 (Suppl 1): S98―103 Masamune A, Shimosegawa T. Pancreatic stellate cells: a dynamic player of the intercellular communication in pancreatic cancer. Clin Res Hepatol Gastroenterol 2015; 39 (Suppl 1): S98―103
30.
Zurück zum Zitat Seyama Y, Kubota K, Kobayashi T, Hirata Y, Itoh A, Makuuchi M (1998)Two-staged pancreatoduodenectomy with external drainage of pancreatic juice and omental graft technique. J Am Coll Surg 187(1):103–105CrossRef Seyama Y, Kubota K, Kobayashi T, Hirata Y, Itoh A, Makuuchi M (1998)Two-staged pancreatoduodenectomy with external drainage of pancreatic juice and omental graft technique. J Am Coll Surg 187(1):103–105CrossRef
31.
Zurück zum Zitat Shah OJ, Bangri SA, Singh M, Lattoo RA, Bhat MY (2015) Omental flaps reduces complications after pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int 14(3):313–319CrossRef Shah OJ, Bangri SA, Singh M, Lattoo RA, Bhat MY (2015) Omental flaps reduces complications after pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int 14(3):313–319CrossRef
Metadaten
Titel
Evaluation of preoperative risk factors for postpancreatectomy hemorrhage
verfasst von
Wataru Izumo
Ryota Higuchi
Takehisa Yazawa
Shuichiro Uemura
Masahiro Shiihara
Masakazu Yamamoto
Publikationsdatum
24.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-019-01830-w

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.